Cancer Genetics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.68 |
Market Cap |
$9.83 M |
Shares Outstanding |
57.82 M |
Public Float |
33.73 M |
Address |
Meadows Office Complex Rutherford New Jersey 07070 United States |
Employees | - |
Website | http://www.cancergenetics.com |
Updated | 07/08/2019 |
Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomaker solutions, biorepository solutions, consulting, cytogenetics testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. |